The abstract is read at the publisher; the summary is JClub's.
Nanomaterial–phage combination strategies are being developed to improve phage stability, detection, targeted delivery, and antibacterial efficacy, addressing key clinical barriers to phage therapy.
- Why it matters: Phage therapy is constrained by poor in vivo stability, immune clearance, narrow host range, resistance induction, and weak activity against biofilms and intracellular bacteria. Existing formulation methods have not been sufficient, and the field’s findings are fragmented across many nanomaterial types.
- What they did: This review systematically consolidates recent research on polymer nanomaterials, liposomes, metal nanomaterials, magnetic nanomaterials, and other platforms, organizing them by the phage functions they enhance. It summarizes reported strategies and mechanisms to provide an integrated design framework.
- The result: The synthesis offers a coherent reference for rationally designing phage–nanomaterial antimicrobial combinations, helping overcome current limitations and guiding more reliable therapeutic development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.